Skip to main content
. 2010 Mar 17;2010(3):CD006114. doi: 10.1002/14651858.CD006114.pub2

3.27. Analysis.

3.27

Comparison 3 Fluvoxamine versus other SSRIs, Outcome 27 Sensitivity analysis ‐ Response (acute phase) 7. Funding ‐ Trials funded by the fluvoxamine marketing company.